<DOC>
	<DOCNO>NCT01097707</DOCNO>
	<brief_summary>The purpose study determine whether LY500307 help symptoms Benign Prostatic Hyperplasia ( BPH )</brief_summary>
	<brief_title>A Study Men With Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<criteria>Present screen history BPH &gt; 6 month . Have IPSS great equal 13 screening . Have Total Prostate Volume Transrectal ultrasound great equal 30 mL screening . Show sign bladder outlet obstruction define peak urinary flow rate ( Qmax ) great equal 4 less equal 15 mL/sec ( prevoid total bladder volume [ assess ultrasound ] great equal 150 less equal 550 ml minimum void volume 125 ml ) screening . Have PSA great equal 1.4 less equal 10 ng/mL screening . Demonstrate Post Void Residual less equal 300 mL ultrasound screening . Have receive following treatment within specified time period : 1 . Finasteride dutasteride least 6 month prior screen . 2 . Any alphaadrenergic antagonist least 4 week prior screen . 3 . Any nonexperimental BPH therapy ( include herbal preparation ) least 4 week prior screen . 4 . Any experimental offlabel BPH therapy injectable therapy protract effect least 6 month prior screen . 5 . Any overactive bladder treatment least 4 week prior screen . 6 . Any Erectile Dysfunction treatment may include oral phosphodiesterase type 5 inhibitor device least 4 week prior screen . Have morning fasting Total Testosterone concentration great equal 300 ng/dL screening . If hyperlipidemic , base history , stable statin treatment determine investigator least 2 month prior screen . Have complete withdrawn study complete withdrawn study investigate LY500307 . Have history BPHrelated invasive procedure ( example , Transurethral Resection Prostate , open prostatectomy , minimally invasive procedure include thermalbased therapy , transurethral microwave treatment , transurethral needle ablation , stent ) . Have active cardiovascular disease evidence follow : 1 . Recent Myocardial infarction , unstable angina , stroke Transient ischemic attach within 6 month screen . 2 . Recent coronary intervention include coronary artery bypass surgery , percutaneous coronary artery intervention , stent placement within 6 month screen . 3 . Recent history positive stress test without write documentation effective intervention within 6 month screen . 4 . Evidence heart disease categorize great equal Class III functional classification NYHA within 6 month screen . Have know suspected history prostate cancer , breast cancer , clinically significant neoplastic disease ( squamous cell basal cell carcinoma skin ) . Have history deep venous thrombosis pulmonary embolism disease . Have moderate severe renal insufficiency . Have hemoglobin A1c ( HbA1c ) great 9.0 % . Are testosterone replacement therapy , drug influence hypothalamuspituitarygonadal axis . Are pharmacological treatment statin hyperlipidemia .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>